Methasterone
Encyclopedia
Methasterone is an oral anabolic steroid
that was never marketed through legitimate channels for medicinal purposes. It was brought to market, instead, in a clandestine fashion as a “designer steroid
.”
in order to discover a compound with anti-tumor properties. This initial mention is elaborated upon in a 1959 research journal article, where its method of synthesis is discussed in greater detail, its tumor inhibiting properties are verified, and it is noted as being a “potent orally active anabolic agent exhibiting only weak androgenic activity.” The results of subsequent assays to determine methasterone’s anabolic and androgenic activity were published in Vida’s Androgens and Anabolic Agents, a dated but still standard reference, where it was noted that methasterone possessed the oral bioavailability of methyl-testosterone while being 400% as anabolic and 20% as androgenic, yielding a Q-ratio (also known as an anabolic to androgenic ratio) of 20, which is considered very high.
, was commercialized by Syntex Corporation under the brand name Masteron.
Anabolic steroid
Anabolic steroids, technically known as anabolic-androgen steroids or colloquially simply as "steroids", are drugs that mimic the effects of testosterone and dihydrotestosterone in the body. They increase protein synthesis within cells, which results in the buildup of cellular tissue ,...
that was never marketed through legitimate channels for medicinal purposes. It was brought to market, instead, in a clandestine fashion as a “designer steroid
Designer drug
Designer drug is a term used to describe drugs that are created to get around existing drug laws, usually by preparing analogs or derivatives of existing drugs by modifying their chemical structure to varying degrees, or less commonly by finding drugs with entirely different chemical structures...
.”
History
The synthesis of methasterone is first mentioned in the literature in 1956 in connection with research conducted by Syntex CorporationSyntex
Laboratorios Syntex SA was a pharmaceutical company formed in Mexico City in 1944 by Russell Marker to manufacture therapeutic steroids from the Mexican yam....
in order to discover a compound with anti-tumor properties. This initial mention is elaborated upon in a 1959 research journal article, where its method of synthesis is discussed in greater detail, its tumor inhibiting properties are verified, and it is noted as being a “potent orally active anabolic agent exhibiting only weak androgenic activity.” The results of subsequent assays to determine methasterone’s anabolic and androgenic activity were published in Vida’s Androgens and Anabolic Agents, a dated but still standard reference, where it was noted that methasterone possessed the oral bioavailability of methyl-testosterone while being 400% as anabolic and 20% as androgenic, yielding a Q-ratio (also known as an anabolic to androgenic ratio) of 20, which is considered very high.
Injectable counterpart
Methasterone was never a commercially available prescription drug. Its non-17α-alkylated counterpart, drostanoloneDrostanolone
Drostanolone is an anabolic steroid. Its main medical applications are to lower cholesterol levels, and as an antineoplastic agent in the treatment of some cancers. It is most commonly marketed as the ester drostanolone propionate .Ringold, H. J.; Batres, E.; Halpern, O.; Necoechea, E.; J. Amer....
, was commercialized by Syntex Corporation under the brand name Masteron.